Search Results - subject:"Beta-blockers"

A cost-benefit analysis of beta-blockers, including the benefits of reducing the symptoms of dementia

Brent, Robert J. - In: Applied economics 57 (2025) 11, pp. 1183-1195

Persistent link: https://www.econbiz.de/10015331605

Control of hypertension in the critically ill: A pathophysiological approach

Salgado, Diamantino; Silva, Eliézer; Vincent, Jean Louis - Solvay Brussels School of Economics and Management, … - 2013

Severe acute arterial hypertension can be associated with significant morbidity and mortality. After excluding a reversible etiology, choice of therapeutic intervention should be based on evaluation of a number of factors, such as age, comorbidities, and other ongoing therapies. A rational...

Persistent link: https://www.econbiz.de/10011011733

Under-Utilisation of beta-Blockers After Acute Myocardial Infarction: Pharmacoeconomic Implications

Bradford, W. David; Chen, Jersey; Krumholz, Harlan M. - In: PharmacoEconomics 15 (1999) 3, pp. 257-268

consequences of under-utilisation. Despite the literature documenting the value of beta-blockers, the therapy is not prescribed at … effective treatments for beta-blockers. For the first category, there is evidence suggesting that around 2900 to 5000 lives are … substitution of calcium channel-blockers for beta-blockers). We conclude that there is a dearth of evidence on the economic …

Persistent link: https://www.econbiz.de/10005243162

Economic Evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany

Schadlich, Peter K.; Paschen, Britta; Brecht, Josef Georg - In: PharmacoEconomics 13 (1998) 1 Part 2, pp. 147-155

The Cardiac Insufficiency Bisoprolol Study (CIBIS) demonstrates that, for patients with heart failure of different aetiologies, administration of the beta1-adrenoceptor blocker bisoprolol as an adjuvant to the standard therapy leads to a significant avoidance of hospital admissions. A...

Persistent link: https://www.econbiz.de/10005590513

Treatment Expectations in Congestive Heart Failure: Implications for Patients Enrolled in Disease Management Programmes

Rich, Michael W. - In: Disease Management and Health Outcomes 4 (1998) 1, pp. 41-49

Heart failure (HF) is a major public health problem which is increasing in prevalence due to the aging of the population. Despite recent advances in the pharmacotherapy of HF, morbidity and mortality rates both remain high, owing in part to the presence of multiple medical, psychosocial,...

Persistent link: https://www.econbiz.de/10005448879